Miromatrix Medical Announces Pricing of Upsized Initial Public Offering
June 24, 2021 07:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., June 24, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (Nasdaq: MIRO) ("Miromatrix"), a life sciences company pioneering a novel technology for bioengineering fully...
Huvepharma Announces the Indicative Price Range, Publication of the Prospectus and Start of the Offer Period of Planned IPO
June 24, 2021 02:15 ET
|
Huvepharma EOOD
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ORINTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION INVIOLATION OF THE RELEVANT...
Monte Rosa Therapeutics Announces Pricing of Initial Public Offering
June 23, 2021 20:20 ET
|
Monte Rosa Therapeutics, Inc.
BOSTON, June 23, 2021 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology company developing a portfolio of novel small molecule precision medicines that employ the...
西安天美生物有限公司宣布扩大IPO融资规模至1100万美元
June 23, 2021 20:00 ET
|
Bon Natural Life Limited
中国西安, June 24, 2021 (GLOBE NEWSWIRE) --...
Bon Natural Life Limited Announces Pricing of Upsized $11 Million Initial Public Offering
June 23, 2021 20:00 ET
|
Bon Natural Life Limited
XIAN, China, June 23, 2021 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and...
FinTech Acquisition Corp. VI Announces Pricing of $220,000,000 Initial Public Offering
June 23, 2021 16:52 ET
|
FINTECH ACQUISITION CORP VI
PHILADELPHIA, PA, June 23, 2021 (GLOBE NEWSWIRE) -- FinTech Acquisition Corp. VI (NASDAQ:FTVIU) (the “Company”), a blank-check company formed for the purpose of acquiring or merging with one or more...
Codex DNA Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
June 22, 2021 16:10 ET
|
Codex DNA, Inc.
SAN DIEGO, June 22, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY) today announced the closing of its initial public offering of 7,666,664 shares of common stock, including the full...
Century Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 22, 2021 16:01 ET
|
Century Therapeutics, Inc.
PHILADELPHIA, June 22, 2021 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in...
Verve Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 21, 2021 16:05 ET
|
Verve Therapeutics
CAMBRIDGE, Mass., June 21, 2021 (GLOBE NEWSWIRE) -- Verve Therapeutics (Nasdaq: VERV), a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene...
Logiq Announces Closing of C$5.9 Million Initial Public Offering in Canada and Begins Trading on the NEO Exchange
June 21, 2021 09:03 ET
|
Logiq, Inc.
NEW YORK, June 21, 2021 (GLOBE NEWSWIRE) -- Logiq, Inc. (“Logiq” or the “Company”) (NEO: LGIQ) (OTCQX: LGIQ), a global provider of award-winning e-commerce and fintech solutions, today announced the...